v3.25.4
Stock Option Plans (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock Option Activity

A summary of changes in options issued under the Company’s stock option plans follows:

 

 

 

2025

 

 

2024

 

Options outstanding at the beginning of the year

 

 

1,403,090

 

 

 

1,598,761

 

Options granted

 

 

113,500

 

 

 

37,500

 

Options forfeited

 

 

(5,437

)

 

 

(10,500

)

Options exercised

 

 

(141,251

)

 

 

(222,671

)

Options outstanding at the end of the year

 

 

1,369,902

 

 

 

1,403,090

 

Options exercisable at the end of the year

 

 

1,140,156

 

 

 

1,126,972

 

Common stock available for future grants at the end of the year

 

 

110,375

 

 

 

223,875

 

Weighted average exercise price per share:

 

 

 

 

 

 

Granted

 

$

40.91

 

 

$

38.26

 

Forfeited

 

 

30.05

 

 

 

31.63

 

Exercised

 

 

23.58

 

 

 

21.87

 

Outstanding

 

 

29.33

 

 

 

27.82

 

Exercisable

 

 

28.12

 

 

 

26.61

 

Summary of Options Outstanding

A summary of options outstanding as December 31, 2025 is as follows:

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

 

Weighted-
Average
Remaining
Contractual
Life (Years)

 

Weighted-
Average
Exercise
Price

 

 

Number
Exercisable

 

 

Weighted-
Average
Exercise
Price

 

$19.23 to $22.86

 

 

285,954

 

 

3

 

$

21.52

 

 

 

285,954

 

 

$

21.52

 

$22.87 to $24.03

 

 

263,512

 

 

4

 

 

23.44

 

 

 

263,512

 

 

 

23.44

 

$24.04 to $29.91

 

 

241,187

 

 

4

 

 

27.31

 

 

 

208,941

 

 

 

27.00

 

$29.92 to $38.09

 

 

255,124

 

 

7

 

 

32.51

 

 

 

158,624

 

 

 

32.88

 

$38.10 to $39.56

 

 

324,125

 

 

7

 

 

40.03

 

 

 

223,125

 

 

 

39.78

 

 

 

 

1,369,902

 

 

 

 

 

 

 

 

1,140,156

 

 

 

 

Assumptions Used to Value Option Grants

The assumptions used to value option grants for the years ended December 31, 2025 and 2024 were as follows:

 

 

 

2025

 

 

2024

 

Expected life in years

 

7

 

 

7

 

Interest rate

 

 

4.14

%

 

 

3.85

%

Volatility

 

0.448

 

 

0.455

 

Dividend yield

 

 

1.5

%

 

 

1.5

%

 

 

Summary of the Status of the Company's Non-Vested Options

A summary of the status of the Company’s non-vested options as of December 31, 2025 and 2024 follows:

 

For the twelve months ended December 31, 2025

 

 

 

 

 

 

 

 

Number of Awards

 

 

Weighted Average Grant Date Fair Value

 

Unvested Outstanding, beginning of year

 

 

276,118

 

 

$

12.91

 

Granted

 

 

113,500

 

 

 

18.34

 

Cancelled/Forfeited

 

 

(3,813

)

 

 

12.00

 

Vested, outstanding shares

 

 

(156,059

)

 

 

13.47

 

Unvested Outstanding, end of year

 

 

229,746

 

 

$

15.23

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the twelve months ended December 31, 2024

 

 

 

 

 

 

 

 

Number of Awards

 

 

Weighted Average Grant Date Fair Value

 

Unvested Outstanding, beginning of year

 

 

460,055

 

 

$

11.81

 

Granted

 

 

37,500

 

 

 

17.16

 

Cancelled/Forfeited

 

 

(8,875

)

 

 

12.00

 

Vested, outstanding shares

 

 

(212,562

)

 

 

11.31

 

Unvested Outstanding, end of year

 

 

276,118

 

 

$

12.91